Asset Details
MbrlCatalogueTitleDetail
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
/ Aged
/ Antibodies, Monoclonal, Humanized - therapeutic use
/ Antirheumatic Agents - therapeutic use
/ Arthritis, Rheumatoid - complications
/ Arthritis, Rheumatoid - drug therapy
/ Coronavirus Infections - complications
/ Coronavirus Infections - mortality
/ Coronavirus Infections - physiopathology
/ COVID-19
/ Female
/ Glucocorticoids - therapeutic use
/ Hospitalization - statistics & numerical data
/ Humans
/ Hydroxychloroquine - therapeutic use
/ Interleukin 1 Receptor Antagonist Protein - therapeutic use
/ Janus Kinase Inhibitors - therapeutic use
/ Letter
/ Male
/ Methotrexate - therapeutic use
/ Nonsteroidal anti-inflammatory drugs
/ Patients
/ Pneumonia, Viral - complications
/ Pneumonia, Viral - mortality
/ Pneumonia, Viral - physiopathology
/ Rheumatic Diseases - complications
/ Rheumatic Diseases - drug therapy
/ Severe acute respiratory syndrome coronavirus 2
/ Spain
/ Spondylarthropathies - complications
/ Spondylarthropathies - drug therapy